CD160 is essential for NK-mediated IFN-γ Production

Tony C. Tu, Nicholas K. Brown, Tae Jin Kim, Joanna Wroblewska, Xuanming Yang, Xiaohuan Guo, Seoyun Hyunji Lee, Vinay Kumar, Kyung-Mi Lee, Yang Xin Fu

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

NK-derived cytokines play important roles for natural killer (NK) function, but how the cytokines are regulated is poorly understood. CD160 is expressed on activated NK or T cells in humans but its function is unknown. We generated CD160-deficient mice to probe its function. Although CD160-/- mice showed no abnormalities in lymphocyte development, the control of NK-sensitive tumors was severely compromised in CD160-/- mice. Surprisingly, the cytotoxicity of NK cells was not impaired, but interferon-γ (IFN-γ) secretion by NK cells was markedly reduced in CD160-/- mice. Functionally targeting CD160 signaling with a soluble CD160-Ig also impaired tumor control and IFN-γ production, suggesting an active role of CD160 signaling. Using reciprocal bone marrow transfer and cell culture, we have identified the intrinsic role of CD160 on NK cells, as well as its receptor on non-NK cells, for regulating cytokine production. To demonstrate sufficiency of the CD160+ NK cell subset in controlling NK-dependent tumor growth, intratumoral transfer of the CD160+ NK fraction led to tumor regression in CD160-/- tumor-bearing mice, indicating demonstrable therapeutic potential for controlling early tumors. Therefore, CD160 is not only an important biomarker but also functionally controls cytokine production by NK cells.

Original languageEnglish
Pages (from-to)415-429
Number of pages15
JournalJournal of Experimental Medicine
Volume212
Issue number3
DOIs
Publication statusPublished - 2015

Fingerprint

Interferons
Natural Killer Cells
Cytokines
Neoplasms
Natural Killer T-Cells
Bone Marrow Cells
Cell Culture Techniques
Biomarkers
Lymphocytes
Growth

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Tu, T. C., Brown, N. K., Kim, T. J., Wroblewska, J., Yang, X., Guo, X., ... Fu, Y. X. (2015). CD160 is essential for NK-mediated IFN-γ Production. Journal of Experimental Medicine, 212(3), 415-429. https://doi.org/10.1084/jem.20131601

CD160 is essential for NK-mediated IFN-γ Production. / Tu, Tony C.; Brown, Nicholas K.; Kim, Tae Jin; Wroblewska, Joanna; Yang, Xuanming; Guo, Xiaohuan; Lee, Seoyun Hyunji; Kumar, Vinay; Lee, Kyung-Mi; Fu, Yang Xin.

In: Journal of Experimental Medicine, Vol. 212, No. 3, 2015, p. 415-429.

Research output: Contribution to journalArticle

Tu, TC, Brown, NK, Kim, TJ, Wroblewska, J, Yang, X, Guo, X, Lee, SH, Kumar, V, Lee, K-M & Fu, YX 2015, 'CD160 is essential for NK-mediated IFN-γ Production', Journal of Experimental Medicine, vol. 212, no. 3, pp. 415-429. https://doi.org/10.1084/jem.20131601
Tu TC, Brown NK, Kim TJ, Wroblewska J, Yang X, Guo X et al. CD160 is essential for NK-mediated IFN-γ Production. Journal of Experimental Medicine. 2015;212(3):415-429. https://doi.org/10.1084/jem.20131601
Tu, Tony C. ; Brown, Nicholas K. ; Kim, Tae Jin ; Wroblewska, Joanna ; Yang, Xuanming ; Guo, Xiaohuan ; Lee, Seoyun Hyunji ; Kumar, Vinay ; Lee, Kyung-Mi ; Fu, Yang Xin. / CD160 is essential for NK-mediated IFN-γ Production. In: Journal of Experimental Medicine. 2015 ; Vol. 212, No. 3. pp. 415-429.
@article{0f7cce12c3064f31b1dbfcf0c7ab7457,
title = "CD160 is essential for NK-mediated IFN-γ Production",
abstract = "NK-derived cytokines play important roles for natural killer (NK) function, but how the cytokines are regulated is poorly understood. CD160 is expressed on activated NK or T cells in humans but its function is unknown. We generated CD160-deficient mice to probe its function. Although CD160-/- mice showed no abnormalities in lymphocyte development, the control of NK-sensitive tumors was severely compromised in CD160-/- mice. Surprisingly, the cytotoxicity of NK cells was not impaired, but interferon-γ (IFN-γ) secretion by NK cells was markedly reduced in CD160-/- mice. Functionally targeting CD160 signaling with a soluble CD160-Ig also impaired tumor control and IFN-γ production, suggesting an active role of CD160 signaling. Using reciprocal bone marrow transfer and cell culture, we have identified the intrinsic role of CD160 on NK cells, as well as its receptor on non-NK cells, for regulating cytokine production. To demonstrate sufficiency of the CD160+ NK cell subset in controlling NK-dependent tumor growth, intratumoral transfer of the CD160+ NK fraction led to tumor regression in CD160-/- tumor-bearing mice, indicating demonstrable therapeutic potential for controlling early tumors. Therefore, CD160 is not only an important biomarker but also functionally controls cytokine production by NK cells.",
author = "Tu, {Tony C.} and Brown, {Nicholas K.} and Kim, {Tae Jin} and Joanna Wroblewska and Xuanming Yang and Xiaohuan Guo and Lee, {Seoyun Hyunji} and Vinay Kumar and Kyung-Mi Lee and Fu, {Yang Xin}",
year = "2015",
doi = "10.1084/jem.20131601",
language = "English",
volume = "212",
pages = "415--429",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "3",

}

TY - JOUR

T1 - CD160 is essential for NK-mediated IFN-γ Production

AU - Tu, Tony C.

AU - Brown, Nicholas K.

AU - Kim, Tae Jin

AU - Wroblewska, Joanna

AU - Yang, Xuanming

AU - Guo, Xiaohuan

AU - Lee, Seoyun Hyunji

AU - Kumar, Vinay

AU - Lee, Kyung-Mi

AU - Fu, Yang Xin

PY - 2015

Y1 - 2015

N2 - NK-derived cytokines play important roles for natural killer (NK) function, but how the cytokines are regulated is poorly understood. CD160 is expressed on activated NK or T cells in humans but its function is unknown. We generated CD160-deficient mice to probe its function. Although CD160-/- mice showed no abnormalities in lymphocyte development, the control of NK-sensitive tumors was severely compromised in CD160-/- mice. Surprisingly, the cytotoxicity of NK cells was not impaired, but interferon-γ (IFN-γ) secretion by NK cells was markedly reduced in CD160-/- mice. Functionally targeting CD160 signaling with a soluble CD160-Ig also impaired tumor control and IFN-γ production, suggesting an active role of CD160 signaling. Using reciprocal bone marrow transfer and cell culture, we have identified the intrinsic role of CD160 on NK cells, as well as its receptor on non-NK cells, for regulating cytokine production. To demonstrate sufficiency of the CD160+ NK cell subset in controlling NK-dependent tumor growth, intratumoral transfer of the CD160+ NK fraction led to tumor regression in CD160-/- tumor-bearing mice, indicating demonstrable therapeutic potential for controlling early tumors. Therefore, CD160 is not only an important biomarker but also functionally controls cytokine production by NK cells.

AB - NK-derived cytokines play important roles for natural killer (NK) function, but how the cytokines are regulated is poorly understood. CD160 is expressed on activated NK or T cells in humans but its function is unknown. We generated CD160-deficient mice to probe its function. Although CD160-/- mice showed no abnormalities in lymphocyte development, the control of NK-sensitive tumors was severely compromised in CD160-/- mice. Surprisingly, the cytotoxicity of NK cells was not impaired, but interferon-γ (IFN-γ) secretion by NK cells was markedly reduced in CD160-/- mice. Functionally targeting CD160 signaling with a soluble CD160-Ig also impaired tumor control and IFN-γ production, suggesting an active role of CD160 signaling. Using reciprocal bone marrow transfer and cell culture, we have identified the intrinsic role of CD160 on NK cells, as well as its receptor on non-NK cells, for regulating cytokine production. To demonstrate sufficiency of the CD160+ NK cell subset in controlling NK-dependent tumor growth, intratumoral transfer of the CD160+ NK fraction led to tumor regression in CD160-/- tumor-bearing mice, indicating demonstrable therapeutic potential for controlling early tumors. Therefore, CD160 is not only an important biomarker but also functionally controls cytokine production by NK cells.

UR - http://www.scopus.com/inward/record.url?scp=84924655166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924655166&partnerID=8YFLogxK

U2 - 10.1084/jem.20131601

DO - 10.1084/jem.20131601

M3 - Article

VL - 212

SP - 415

EP - 429

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 3

ER -